nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Trismus—Riluzole—amyotrophic lateral sclerosis	0.0621	0.063	CcSEcCtD
Cefuroxime—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0545	0.0553	CcSEcCtD
Cefuroxime—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0416	0.0422	CcSEcCtD
Cefuroxime—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.0411	0.0416	CcSEcCtD
Cefuroxime—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0394	0.04	CcSEcCtD
Cefuroxime—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0394	0.04	CcSEcCtD
Cefuroxime—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.0379	0.0384	CcSEcCtD
Cefuroxime—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0301	0.0305	CcSEcCtD
Cefuroxime—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0234	CcSEcCtD
Cefuroxime—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0219	0.0222	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0207	0.021	CcSEcCtD
Cefuroxime—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0201	CcSEcCtD
Cefuroxime—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0197	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0175	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0175	CcSEcCtD
Cefuroxime—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0158	0.016	CcSEcCtD
Cefuroxime—Cefazolin—PON1—amyotrophic lateral sclerosis	0.0141	1	CrCbGaD
Cefuroxime—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0127	CcSEcCtD
Cefuroxime—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0125	CcSEcCtD
Cefuroxime—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0123	CcSEcCtD
Cefuroxime—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0123	CcSEcCtD
Cefuroxime—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0118	CcSEcCtD
Cefuroxime—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0118	CcSEcCtD
Cefuroxime—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0115	CcSEcCtD
Cefuroxime—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0115	CcSEcCtD
Cefuroxime—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0114	CcSEcCtD
Cefuroxime—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0113	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.011	0.0111	CcSEcCtD
Cefuroxime—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0109	0.011	CcSEcCtD
Cefuroxime—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.011	CcSEcCtD
Cefuroxime—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0106	CcSEcCtD
Cefuroxime—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0106	CcSEcCtD
Cefuroxime—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0106	CcSEcCtD
Cefuroxime—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0104	CcSEcCtD
Cefuroxime—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0103	CcSEcCtD
Cefuroxime—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00984	0.00998	CcSEcCtD
Cefuroxime—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00944	0.00957	CcSEcCtD
Cefuroxime—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0094	0.00953	CcSEcCtD
Cefuroxime—Chills—Riluzole—amyotrophic lateral sclerosis	0.00934	0.00947	CcSEcCtD
Cefuroxime—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00892	0.00905	CcSEcCtD
Cefuroxime—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00871	0.00883	CcSEcCtD
Cefuroxime—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00832	0.00844	CcSEcCtD
Cefuroxime—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00828	0.00839	CcSEcCtD
Cefuroxime—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00811	0.00822	CcSEcCtD
Cefuroxime—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.008	0.00812	CcSEcCtD
Cefuroxime—Cough—Riluzole—amyotrophic lateral sclerosis	0.0079	0.00802	CcSEcCtD
Cefuroxime—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00785	0.00796	CcSEcCtD
Cefuroxime—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00771	0.00782	CcSEcCtD
Cefuroxime—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00771	0.00782	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00766	0.00777	CcSEcCtD
Cefuroxime—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00739	0.0075	CcSEcCtD
Cefuroxime—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00724	0.00734	CcSEcCtD
Cefuroxime—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00721	0.00732	CcSEcCtD
Cefuroxime—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00718	0.00728	CcSEcCtD
Cefuroxime—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00715	0.00725	CcSEcCtD
Cefuroxime—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00705	0.00715	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00683	CcSEcCtD
Cefuroxime—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00659	0.00668	CcSEcCtD
Cefuroxime—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00667	CcSEcCtD
Cefuroxime—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00651	0.0066	CcSEcCtD
Cefuroxime—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00643	0.00652	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00638	0.00647	CcSEcCtD
Cefuroxime—Pain—Riluzole—amyotrophic lateral sclerosis	0.00632	0.00641	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00613	CcSEcCtD
Cefuroxime—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00596	CcSEcCtD
Cefuroxime—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00593	CcSEcCtD
Cefuroxime—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00593	CcSEcCtD
Cefuroxime—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00545	0.00552	CcSEcCtD
Cefuroxime—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00523	0.0053	CcSEcCtD
Cefuroxime—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00513	CcSEcCtD
Cefuroxime—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00496	CcSEcCtD
Cefuroxime—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00477	CcSEcCtD
Cefuroxime—Rash—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00473	CcSEcCtD
Cefuroxime—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00472	CcSEcCtD
Cefuroxime—Headache—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0047	CcSEcCtD
Cefuroxime—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00445	CcSEcCtD
